1. Home
  2. MRBK vs BNR Comparison

MRBK vs BNR Comparison

Compare MRBK & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Meridian Corporation

MRBK

Meridian Corporation

HOLD

Current Price

$20.17

Market Cap

222.3M

Sector

Finance

ML Signal

HOLD

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$20.64

Market Cap

252.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRBK
BNR
Founded
2004
2014
Country
United States
China
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
222.3M
252.7M
IPO Year
2018
2019

Fundamental Metrics

Financial Performance
Metric
MRBK
BNR
Price
$20.17
$20.64
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$20.00
N/A
AVG Volume (30 Days)
119.3K
33.1K
Earning Date
04-28-2026
06-05-2026
Dividend Yield
2.77%
N/A
EPS Growth
30.34
N/A
EPS
1.89
N/A
Revenue
$6,316,000.00
N/A
Revenue This Year
$25.40
$111.65
Revenue Next Year
$8.15
N/A
P/E Ratio
$10.68
N/A
Revenue Growth
10.13
N/A
52 Week Low
$11.17
$2.18
52 Week High
$21.59
$41.72

Technical Indicators

Market Signals
Indicator
MRBK
BNR
Relative Strength Index (RSI) 60.93 54.25
Support Level $18.32 $19.72
Resistance Level $20.86 $23.80
Average True Range (ATR) 0.54 1.45
MACD 0.03 0.76
Stochastic Oscillator 51.25 76.52

Price Performance

Historical Comparison
MRBK
BNR

About MRBK Meridian Corporation

Meridian Corp is a bank holding company based in the United States. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal and business lending and deposit services. It operates in three reportable segments, including Bank, Wealth, and Mortgage. Meridian generates maximum revenue from the Bank segment, which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans. Geographically, it operates in Pennsylvania, New Jersey, and Delaware, as well as in the Central Maryland market and southwest Florida, U.S.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Share on Social Networks: